Cornerstone Select Advisors LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 479 shares of the medical equipment provider's stock, valued at approximately $250,000.
Several other large investors also recently modified their holdings of ISRG. Principal Financial Group Inc. lifted its holdings in shares of Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock worth $295,938,000 after buying an additional 9,194 shares in the last quarter. World Investment Advisors LLC acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $228,000. Nordea Investment Management AB increased its holdings in shares of Intuitive Surgical by 31.7% during the fourth quarter. Nordea Investment Management AB now owns 43,200 shares of the medical equipment provider's stock worth $22,632,000 after purchasing an additional 10,405 shares during the period. Diversified Trust Co boosted its stake in shares of Intuitive Surgical by 0.6% in the fourth quarter. Diversified Trust Co now owns 4,383 shares of the medical equipment provider's stock valued at $2,288,000 after buying an additional 25 shares during the period. Finally, One Wealth Capital Management LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $255,000. 83.64% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts have commented on ISRG shares. Barclays decreased their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Wells Fargo & Company boosted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Truist Financial cut their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, UBS Group increased their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $598.95.
Get Our Latest Research Report on Intuitive Surgical
Insider Transactions at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,695,113.84. This represents a 3.47 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company's stock, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,313 shares of company stock worth $17,229,143 over the last quarter. Corporate insiders own 0.70% of the company's stock.
Intuitive Surgical Stock Performance
ISRG traded down $1.61 during midday trading on Friday, reaching $536.55. The company had a trading volume of 925,598 shares, compared to its average volume of 1,628,568. Intuitive Surgical, Inc. has a 12-month low of $379.67 and a 12-month high of $616.00. The business has a 50-day moving average price of $500.93 and a two-hundred day moving average price of $534.71. The stock has a market cap of $192.31 billion, a PE ratio of 83.71, a P/E/G ratio of 5.85 and a beta of 1.70.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the prior year, the company earned $1.50 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.